Expert guides on GLP-1 coverage, regulatory liability, product recall insurance, and risk management for the peptide industry.
Running a peptide company puts more than products at risk—it puts the people at the top in the crosshairs. D&O insurance protects executives, board members, and founders from personal financial liability in the heavily scrutinized peptide industry.
Peptide businesses face a uniquely complex web of product liability, regulatory, and professional risks that standard commercial insurance simply wasn't built for. Here's why adequate, specialized coverage isn't optional — it's a business survival issue.
The FDA has officially removed semaglutide and tirzepatide from its drug shortage list — and enforcement against compounding pharmacies is accelerating. Here's what your pharmacy needs to know about compliance, liability exposure, and insurance right now.
Telehealth weight loss platforms and clinics prescribing or dispensing compounded semaglutide face a complex insurance landscape. This guide explains the coverage you need — and the gaps most programs miss.
Research peptide companies selling BPC-157, TB-500, PT-141, and similar compounds face real liability exposure — even when products are labeled 'not for human use.' Here's what the right coverage looks like.
Whether you're selling research peptides, compounded GLP-1 medications, or peptide-based supplements, the liability exposure is real — and the insurance requirements may be more complex than you think.
A single contaminated peptide batch can trigger a recall costing hundreds of thousands of dollars. Product recall insurance covers the costs most businesses never plan for — until it's too late.
Compounding pharmacies operate under some of the most complex regulatory frameworks in healthcare. Here's what 503A and 503B pharmacies need to know about liability insurance — and why standard pharmacy policies fall short.
Generic commercial insurance policies were designed for general businesses—not for companies operating in the highly regulated peptide industry. Here's why specialized coverage matters and what happens when you rely on the wrong policy.
Peptide distributors and suppliers occupy a critical—and risky—position in the supply chain. Errors & Omissions insurance protects you when your professional guidance, documentation, or representations lead to a downstream claim.
The FDA and FTC have both increased enforcement activity in the peptide space. Regulatory defense insurance can mean the difference between surviving an investigation and being shut down.
Manufacturing peptides—whether as bulk API, research chemicals, or finished formulations—creates significant product liability exposure. This guide explains what peptide manufacturers need to know about protecting their business.
GLP-1 medications like semaglutide and tirzepatide have transformed obesity and diabetes treatment—but they've also created serious liability exposure for clinics and compounding pharmacies. Here's what you need to know about protecting your practice.
Get a competitive quote from A-rated specialty carriers tailored to the peptide industry.